[gnso-gac-closed-generics] Closed Generics Asynchronous Work

Nigel Hickson nigel.hickson at dcms.gov.uk
Wed May 24 06:10:46 UTC 2023


Christian cc as above

Good morning; echo Kathy here; thanks for this and all your excellent
support;

best

Nigel

On Wed, 24 May 2023 at 02:10, Kathy Kleiman <Kathy at kathykleiman.com> wrote:

> Hi Christian,
>
> It's a huge help!
>
> Many thanks, Kathy
> On 5/23/2023 7:49 PM, Christian Wheeler wrote:
>
> Hi Kathy,
>
>
>
> Per your request, I’ve gone through the Remaining Red Lines
> <https://docs.google.com/document/d/1smLEk84K113gSGEdM4b_o1VR0vMmJk4yIkmkxX4M6Zc/edit>
> table and added which section/block each Red Line came from in the v2
> document
> <https://docs.google.com/document/d/1wtLVcyWhyrCaYl1iqlAncaIyrqpS--0aPCTjpwMue7I/edit?pli=1>.
> If you look just beneath the title of each topic (e.g. “*Scoring*”) you
> will find the relevant information (“*From **v2 Discussion Draft*
> <https://docs.google.com/document/d/1wtLVcyWhyrCaYl1iqlAncaIyrqpS--0aPCTjpwMue7I/edit?pli=1>*:
> Section IV (Evaluation) #6”*). I hope this helps.
>
>
>
> Kind regards,
>
> Christian
>
>
>
>
>
> *From: *gnso-gac-closed-generics
> <gnso-gac-closed-generics-bounces at icann.org>
> <gnso-gac-closed-generics-bounces at icann.org> on behalf of Kathy Kleiman
> <Kathy at KathyKleiman.com> <Kathy at KathyKleiman.com>
> *Date: *Tuesday, May 23, 2023 at 3:37 PM
> *To: *"gnso-gac-closed-generics at icann.org"
> <gnso-gac-closed-generics at icann.org> <gnso-gac-closed-generics at icann.org>
> <gnso-gac-closed-generics at icann.org>, Melissa Peters Allgood
> <melissa.allgood at icann.org> <melissa.allgood at icann.org>
> *Subject: *Re: [gnso-gac-closed-generics] Closed Generics Asynchronous
> Work
>
>
>
> Hi Melissa,
>
> Is there any way that you/Christian could go through #1, Remaining Red
> Lines Table, in the left column and identify which "Block" of our Framework
> the section came from, e.g.,
>
> - Application, Evaluation or Post-delegation?
>
> Out of context, things are looking a little duplicative and it may be
> because they are coming from different sections of our Framework.  If you
> remember, it was my job, with Greg *specifically to move some items from
> Evaluation to Application* (keeping them in Evaluation, but also giving
> the Applicant an opportunity to provide input directly on an issue to be
> evaluated by the Panel).
>
> If we can see these section headings a little more clearly, it will
> provide some usual context for the sections we are discussing.
>
> Best and tx, Kathy
>
> On 5/22/2023 6:48 PM, Melissa Peters Allgood wrote:
>
> Hello again,
>
>
>
> Many thanks again for the strong spirit of compromise shared by all during
> today’s call.
>
>
>
> This is the email chain that encapsulates remaining work, specifically:
>
>    1. Remaining Red lines table [docs.google.com]
>    <https://urldefense.com/v3/__https:/docs.google.com/document/d/1smLEk84K113gSGEdM4b_o1VR0vMmJk4yIkmkxX4M6Zc/edit__;!!PtGJab4!83OPcACa9MYyzeaFCIsE3nfprdMk9E7AnuE0YDcnqoykfPNVehO6PyS9ayT3iMHHigwyjBxDtndJrAnVw9jAOeYWCPrAc5k$>
>    2. Add notable concerns to v3 [docs.google.com]
>    <https://urldefense.com/v3/__https:/docs.google.com/document/d/1u0Nb9_CJ-6R_ZF4bt9wbkzxLhMKu64aKY_vzS3QixgQ/edit__;!!PtGJab4!83OPcACa9MYyzeaFCIsE3nfprdMk9E7AnuE0YDcnqoykfPNVehO6PyS9ayT3iMHHigwyjBxDtndJrAnVw9jAOeYWAgn-Cok$>.
>
>
>
>
> Please don’t hesitate to reach out if you have any questions.
>
>
>
> Melissa
>
>
>
>
>
> *From: *gnso-gac-closed-generics
> <gnso-gac-closed-generics-bounces at icann.org>
> <gnso-gac-closed-generics-bounces at icann.org> on behalf of Melissa Peters
> Allgood <melissa.allgood at icann.org> <melissa.allgood at icann.org>
> *Date: *Monday, May 22, 2023 at 8:08 AM
> *To: *"gnso-gac-closed-generics at icann.org"
> <gnso-gac-closed-generics at icann.org> <gnso-gac-closed-generics at icann.org>
> <gnso-gac-closed-generics at icann.org>
> *Subject: *Re: [gnso-gac-closed-generics] Closed Generics Asynchronous
> Work
>
>
>
> Hello,
>
>
>
> Just a reminder to review and respond to the work detailed below. My
> thanks to those who have already done so.
>
>
>
> See you later today,
>
> Melissa
>
>
>
> *From: *gnso-gac-closed-generics
> <gnso-gac-closed-generics-bounces at icann.org>
> <gnso-gac-closed-generics-bounces at icann.org> on behalf of Melissa Peters
> Allgood <melissa.allgood at icann.org> <melissa.allgood at icann.org>
> *Date: *Thursday, May 18, 2023 at 2:50 PM
> *To: *"gnso-gac-closed-generics at icann.org"
> <gnso-gac-closed-generics at icann.org> <gnso-gac-closed-generics at icann.org>
> <gnso-gac-closed-generics at icann.org>
> *Subject: *[gnso-gac-closed-generics] Closed Generics Asynchronous Work
>
>
>
> Hello all,
>
>
>
> While you have come a long way toward a draft framework, significant work
> remains with very little time to do it. I encourage you to view the work
> remaining through a lens of compromise.
>
>
>
> *Remaining Red Lines [docs.google.com]
> <https://urldefense.com/v3/__https:/docs.google.com/document/d/1smLEk84K113gSGEdM4b_o1VR0vMmJk4yIkmkxX4M6Zc/edit__;!!PtGJab4!5OCuWteNnOZUXddYUk9Q7E0rVWeyo0c0Y2jQ1dTTnNSqPBoPDk_dYnCKqeN5DQQYg5JhqXO29H0fkvkQkToY8EouDljKSQYSpUk18Q$>*
>
> This table reflects where each remaining red line issue currently stands.
> The group has recently worked on the vast majority of these and many issues
> within the table offer proposed compromise. At this point, your positions
> on each issue are well known and there is no need to restate them. Instead,
> in this table I ask you find compromise with the language proposed OR offer
> possible solutions that meet your needs, as well as the needs of your
> colleagues.
>
>
>
> Due to time constraints, it is now incumbent upon each of you to find
> strong support for your priority issues within the red line table in order
> for the issue to be included within the Closed Generic Framework v3
> document. [docs.google.com]
> <https://urldefense.com/v3/__https:/docs.google.com/document/d/1u0Nb9_CJ-6R_ZF4bt9wbkzxLhMKu64aKY_vzS3QixgQ/edit__;!!PtGJab4!5OCuWteNnOZUXddYUk9Q7E0rVWeyo0c0Y2jQ1dTTnNSqPBoPDk_dYnCKqeN5DQQYg5JhqXO29H0fkvkQkToY8EouDljKSQY6fzo4dg$>
>
>
>
> *Detailed Solutions to your “Notable Concerns” in v3 Document*
>
> If you flagged specific text as a “notable concern” during our red line
> discussions (this was the final question I asked for each bit of text under
> discussion) then please share proposed solutions to your concern(s) *via
> comments* in the v3 document [docs.google.com]
> <https://urldefense.com/v3/__https:/docs.google.com/document/d/1u0Nb9_CJ-6R_ZF4bt9wbkzxLhMKu64aKY_vzS3QixgQ/edit__;!!PtGJab4!5OCuWteNnOZUXddYUk9Q7E0rVWeyo0c0Y2jQ1dTTnNSqPBoPDk_dYnCKqeN5DQQYg5JhqXO29H0fkvkQkToY8EouDljKSQY6fzo4dg$>
>  as soon as possible.
>
>
>
> *Minority Statements *
>
> We haven’t seen strong support for this option.
>
>
>
> *Remaining Calls*
>
>    1. 22 May 2023 at 20:00 UTC
>    2. 24 May 2023 at 20:00 UTC
>
>
>
> Thank you for your continued hard work, especially asynchronously. The
> finish line is in sight.
>
>
>
>
>
> All the best,
>
> Melissa
>
>
>
> _______________________________________________
>
> gnso-gac-closed-generics mailing list
>
> gnso-gac-closed-generics at icann.org
>
> https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics
>
>
>
> _______________________________________________
>
> By submitting your personal data, you consent to the processing of your personal data for purposes of subscribing to this mailing list accordance with the ICANN Privacy Policy (https://www.icann.org/privacy/policy) and the website Terms of Service (https://www.icann.org/privacy/tos). You can visit the Mailman link above to change your membership status or configuration, including unsubscribing, setting digest-style delivery or disabling delivery altogether (e.g., for a vacation), and so on.
>
> _______________________________________________
> gnso-gac-closed-generics mailing list
> gnso-gac-closed-generics at icann.org
> https://mm.icann.org/mailman/listinfo/gnso-gac-closed-generics
>
> _______________________________________________
> By submitting your personal data, you consent to the processing of your
> personal data for purposes of subscribing to this mailing list accordance
> with the ICANN Privacy Policy (https://www.icann.org/privacy/policy) and
> the website Terms of Service (https://www.icann.org/privacy/tos). You can
> visit the Mailman link above to change your membership status or
> configuration, including unsubscribing, setting digest-style delivery or
> disabling delivery altogether (e.g., for a vacation), and so on.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://mm.icann.org/pipermail/gnso-gac-closed-generics/attachments/20230524/d4750f47/attachment-0001.html>


More information about the gnso-gac-closed-generics mailing list